Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ARDX Ardelyx Inc
- Stocks
- Healthcare
- NASDAQ: ARDX
Price (delayed)
$4.48
Market cap
$1.07B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.22
Enterprise value
$1.2B
Ardelyx is focused on discovering, developing, and commercializing innovative first-in-class medicines to enhance the lives of patients with kidney and cardiorenal diseases. Ardelyx is advancing tenapanor, a novel product candidate
Highlights
The company's revenue has surged by 127% YoY and by 8% QoQ
The company's gross profit has surged by 125% YoY and by 8% QoQ
The net income has decreased by 37% from the previous quarter but it has increased by 18% YoY
The EPS has declined by 29% since the previous quarter but it has increased by 24% year-on-year
Ardelyx's debt has increased by 48% YoY
Ardelyx's equity has decreased by 16% QoQ and by 3.5% YoY
Key stats
What are the main financial stats of ARDX
Market
Valuations
Earnings
Shares outstanding
239.26M
Market cap
$1.07B
Enterprise value
$1.2B
Price to earnings (P/E)
N/A
Price to book (P/B)
7.33
Price to sales (P/S)
2.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.31
Revenue
$361.71M
Gross profit
$305.98M
Operating income
-$39.62M
Net income
-$53.76M
EBIT
-$37.92M
EBITDA
-$31.7M
Free cash flow
-$48.73M
Per share
Balance sheet
Liquidity
EPS
-$0.22
EPS diluted
-$0.22
Free cash flow per share
-$0.2
Book value per share
$0.61
Revenue per share
$1.52
TBVPS
$1.72
Total assets
$410.19M
Total liabilities
$264.52M
Debt
$155.11M
Equity
$145.68M
Working capital
$236.85M
Debt to equity
1.06
Current ratio
4.12
Quick ratio
3.43
Net debt/EBITDA
-3.92
Margins
Efficiency
Dividend
EBITDA margin
-8.8%
Gross margin
84.6%
Net margin
-14.9%
Operating margin
-11%
Return on assets
-13.8%
Return on equity
-34.4%
Return on invested capital
-9.5%
Return on capital employed
-11.3%
Return on sales
-10.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ARDX stock price
How has the Ardelyx stock price performed over time
Intraday
2.99%
1 week
14.87%
1 month
21.74%
1 year
-17.8%
YTD
-11.64%
QTD
14.29%
Financial performance
How have Ardelyx's revenue and profit performed over time
Revenue
$361.71M
Gross profit
$305.98M
Operating income
-$39.62M
Net income
-$53.76M
Gross margin
84.6%
Net margin
-14.9%
The company's revenue has surged by 127% YoY and by 8% QoQ
The company's gross profit has surged by 125% YoY and by 8% QoQ
ARDX's operating margin has surged by 72% year-on-year but it is down by 31% since the previous quarter
Ardelyx's net margin has surged by 64% YoY but it has decreased by 27% QoQ
Price vs fundamentals
How does ARDX's price correlate with its fundamentals
Growth
What is Ardelyx's growth rate over time
Valuation
What is Ardelyx stock price valuation
P/E
N/A
P/B
7.33
P/S
2.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.31
The EPS has declined by 29% since the previous quarter but it has increased by 24% year-on-year
ARDX's P/B is 26% above its 5-year quarterly average of 5.8 but 21% below its last 4 quarters average of 9.3
Ardelyx's equity has decreased by 16% QoQ and by 3.5% YoY
The company's revenue has surged by 127% YoY and by 8% QoQ
The price to sales (P/S) is 87% lower than the 5-year quarterly average of 22.4 and 45% lower than the last 4 quarters average of 5.4
Efficiency
How efficient is Ardelyx business performance
The return on sales has surged by 72% year-on-year but it has declined by 35% since the previous quarter
The company's return on invested capital has surged by 58% YoY but it fell by 38% QoQ
Ardelyx's ROA has increased by 40% YoY but it has decreased by 31% from the previous quarter
Ardelyx's ROE has decreased by 38% from the previous quarter but it has increased by 18% YoY
Dividends
What is ARDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ARDX.
Financial health
How did Ardelyx financials performed over time
ARDX's total assets is 55% greater than its total liabilities
ARDX's total liabilities is up by 38% year-on-year
ARDX's total assets is up by 20% year-on-year but it is down by 6% since the previous quarter
Ardelyx's debt is 6% higher than its equity
Ardelyx's debt to equity has surged by 51% YoY and by 19% QoQ
Ardelyx's debt has increased by 48% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.